AGP Executive Report
Last update: 2 hours agoMiddle East Tensions: Trump escalated threats after Iran’s Khamenei funeral amid demands for a public Strait of Hormuz pledge, as strikes and retaliations rattled an interim ceasefire and raised risks for shipping and global costs. Public Health & Safety: CDC reported a U.S. citizen in the DRC with Bundibugyo Ebola and is coordinating contact tracing; separately, a fast-moving cyclosporiasis surge is driving new state alerts and hospitalizations. Healthcare Access & Workforce: Florida nursing homes warned Haitian TPS lapses could worsen long-term care staffing shortages; meanwhile, Medicare’s 2026 changes and record GLP-1 uptake are reshaping costs and coverage decisions for seniors. Medical Innovation: FDA approved Sanofi’s wearable Sarclisa injector for multiple myeloma, and a Michigan Medicine study suggests an experimental drug could reverse severe fatty liver disease by targeting gut-liver pathways. Policy & Oversight: A House committee launched an inquiry into major pharma clinical trials at China military-linked hospitals; states also pressed Meta for alleged child addiction design. Fraud & Data Privacy: A federal case unsealed a $8M+ romance scam indictment targeting elderly victims, and a new warning highlights how wearable health data can be sold.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
